Henderson Group »

Enliven Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 729k 23.35
2024-03-31 $13M 714k 17.66
2023-12-31 $5.7M 409k 13.90
2023-09-30 $3.8M 276k 13.64
2023-06-30 $7.6M 371k 20.41
2023-03-31 $13M 602k 21.89